542 reports of this reaction
3.3% of all CEFAZOLIN reports
#2 most reported adverse reaction
HYPOTENSION is the #2 most commonly reported adverse reaction for CEFAZOLIN, manufactured by Apotex Corp.. There are 542 FDA adverse event reports linking CEFAZOLIN to HYPOTENSION. This represents approximately 3.3% of all 16,465 adverse event reports for this drug.
Patients taking CEFAZOLIN who experience hypotension should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPOTENSION is moderately reported among CEFAZOLIN users, representing a notable but not dominant share of adverse events.
In addition to hypotension, the following adverse reactions have been reported for CEFAZOLIN:
The following drugs have also been linked to hypotension in FDA adverse event reports:
HYPOTENSION has been reported as an adverse event in 542 FDA reports for CEFAZOLIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPOTENSION accounts for approximately 3.3% of all adverse event reports for CEFAZOLIN, making it one of the most commonly reported side effect.
If you experience hypotension while taking CEFAZOLIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.